8-KLeadership Changes

AbbVie Inc. 8-K Report, Executive Changes (Dec 13, 2024)

Filed December 13, 2024For Securities:ABBV

Summary

This 8-K filing from AbbVie Inc. announces a key executive transition within its finance department. Kevin K. Buckbee, Senior Vice President and Controller, has indicated his planned retirement effective March 1, 2025. This marks the end of Mr. Buckbee's tenure in the Controller role, and the company has appointed David R. Purdue to succeed him. Mr. Purdue, currently Vice President, Controller, Commercial Operations, brings extensive experience within AbbVie and its former parent, Abbott Laboratories. His appointment as Senior Vice President, Controller will be effective on the same date as Mr. Buckbee's retirement. Investors should note Mr. Purdue's new compensation package, including a base salary of $550,000 and eligibility for a performance-based bonus plan, reflecting the importance of this role in financial oversight and strategy.

Key Highlights

  • 1Kevin K. Buckbee, Senior Vice President and Controller, plans to retire effective March 1, 2025.
  • 2David R. Purdue appointed as the new Senior Vice President, Controller, effective March 1, 2025.
  • 3Mr. Purdue has a long history with AbbVie and Abbott Laboratories, holding various finance leadership roles.
  • 4Mr. Purdue's new annual base salary will be $550,000.
  • 5Mr. Purdue is eligible for a performance-based bonus plan with a target bonus of 85% of his base salary.
  • 6The filing is classified as an 8-K Current Report, signaling a material event.

Frequently Asked Questions